nitrites has been researched along with metoprolol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG | 1 |
Cemri, M; Cengel, A; Erdamar, H; Okuyan, H; Poyraz, F; Sen, N; Tavil, Y; Topal, S; Turfan, M; Yazici, HU | 1 |
Botker, HE; Engstrom, T; Erlinge, D; Garcia-Dorado, D; Hausenloy, DJ; Heusch, G; Ibanez, B; Kloner, RA; Ovize, M; Yellon, DM | 1 |
1 trial(s) available for nitrites and metoprolol
Article | Year |
---|---|
The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X.
Topics: Adrenergic beta-Antagonists; Adult; Antioxidants; Benzopyrans; Biomarkers; Ethanolamines; Exercise Test; Female; Humans; Male; Malondialdehyde; Metoprolol; Microvascular Angina; Middle Aged; Nebivolol; Nitrates; Nitrites; Oxidative Stress; Peroxidase; Prospective Studies; Single-Blind Method; Superoxide Dismutase; Time Factors; Treatment Outcome | 2009 |
2 other study(ies) available for nitrites and metoprolol
Article | Year |
---|---|
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection | 2009 |
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
Topics: Adenosine; Cardiotonic Agents; Clinical Trials as Topic; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Enzyme Inhibitors; Humans; Hypothermia, Induced; Ischemic Postconditioning; Metoprolol; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide; Nitrites; Nucleotides, Cyclic; Oligopeptides; Oximes; Patient Selection; Protein Kinase C; Secosteroids; Signal Transduction; ST Elevation Myocardial Infarction; Vasodilator Agents | 2017 |